Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its pipeline of small molecule kinase inhibitors include ELVN-001, which is being …
Biotechnology
US, Boulder [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Enliven Therapeutics, Inc. has no acquisition track records yet.
M&A Deals · History
Enliven Therapeutics, Inc. has no acquisition track records yet.